A device designed to capture more TAVR procedural debris proves noninferior to an existing device in a large trial, but the ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

The question remains: what will it take to prove that any protection device is having a meaningful impact on stroke risk?

Please provide your email address to receive an email when new articles are posted on . Routine cerebral embolic protection did not reduce stroke in patients undergoing transcatheter aortic valve ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within ...

In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter ...

Emboline's Emboliner system excels in a global trial, showing superior debris capture and procedural success in TAVR patients ...

US hospitals pulled back on their use of cerebral embolic protection during TAVI after publication of the PROTECTED TAVR results, a new analysis affirms. The proportion of procedures done with the ...